Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma (2022)
- Authors:
- USP affiliated authors: LOTUFO, LETICIA VERAS COSTA - ICB ; HIRATA, AMANDA SOARES - ICB
- Unidade: ICB
- DOI: 10.3390/md20050301
- Subjects: FARMACOLOGIA; CÉLULAS CULTIVADAS DE TUMOR; APOPTOSE; PRODUTOS NATURAIS; MELANOMA; NEOPLASIAS CUTÂNEAS; MOLÉCULA; INFECÇÕES BACTERIANAS GRAM-POSITIVAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Marine Drugs
- ISSN: 1660-3397
- Volume/Número/Paginação/Ano: v. 20, n. 5, art. 301, p. 1-13, 2022
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
HIRATA, Amanda Soares et al. Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma. Marine Drugs, v. 20, n. 5, p. 1-13, 2022Tradução . . Disponível em: https://doi.org/10.3390/md20050301. Acesso em: 27 dez. 2025. -
APA
Hirata, A. S., Clair, J. J. L., Jimenez, P. C., Costa-Lotufo, L. V., & Fenical, W. (2022). Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma. Marine Drugs, 20( 5), 1-13. doi:10.3390/md20050301 -
NLM
Hirata AS, Clair JJL, Jimenez PC, Costa-Lotufo LV, Fenical W. Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma [Internet]. Marine Drugs. 2022 ; 20( 5): 1-13.[citado 2025 dez. 27 ] Available from: https://doi.org/10.3390/md20050301 -
Vancouver
Hirata AS, Clair JJL, Jimenez PC, Costa-Lotufo LV, Fenical W. Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma [Internet]. Marine Drugs. 2022 ; 20( 5): 1-13.[citado 2025 dez. 27 ] Available from: https://doi.org/10.3390/md20050301 - Caracterização do mecanismo de ação da seriniquinona e derivados sintéticos em modelos celulares de melanoma
- Beyond formulation: contributions of nanotechnology for translation of anticancer natural products into new drugs
- Seriniquinone, metabolite from a marine bacterium, and its synthetic derivative for melanoma and resistant melanoma cells treatment
- Seriniquinones as therapeutic leads for treatment of BRAF and NRAS mutant melanomas
- Bismuth(III) triflate: an economical and environmentally friendly catalyst for the Nazarov reaction
- Metabolomic fingerprinting of Brazilian marine sponges: a case study of Plakinidae species from Fernando de Noronha Archipelago
- Steroids from the Brazilian Zoanthids Palythoa caribaeorum and Palythoa variabilis
- Substâncias bioativas em Phallusia nigra (Savigny, 1816) (Urochordata, Ascidiaceae)
- Dinoflagellate-Related Amphidinolides from the Brazilian Octocoral Stragulum bicolor
- The Brazilian octocoral Phyllogorgia dilatata as a source of cytotoxic compounds
Informações sobre o DOI: 10.3390/md20050301 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
Preclinical Development o... | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
